120 related articles for article (PubMed ID: 1189778)
41. Intrartum management of the pregnant patient with heart disease.
Freeman RK
Clin Obstet Gynecol; 1975 Sep; 18(3):75-9. PubMed ID: 1157369
[No Abstract] [Full Text] [Related]
42. [Evaluation of the changes of natural resistance in patients with diffuse peritonitis].
Venglinskaia EA; Polianskiĭ VA
Vestn Khir Im I I Grek; 1976 Feb; 116(2):81-3. PubMed ID: 960471
[TBL] [Abstract][Full Text] [Related]
43. [The importance of indices of non-specific immunity in gynecologic patients].
Malkov IaIu
Akush Ginekol (Mosk); 1971 Jul; 47(7):60-2. PubMed ID: 5155338
[No Abstract] [Full Text] [Related]
44. [General and non-specific immunologic reactivity in pregnant women and gynecologic patients].
Foĭ AM; Malkov IaIu; Ioannesian-Zverkova BI
Akush Ginekol (Mosk); 1971 Oct; 47(10):50-3. PubMed ID: 5161507
[No Abstract] [Full Text] [Related]
45. [Prognostic importance of the indices of natural resistance and of C-reactive protein in diseases of septic origin].
Malkov IaIu
Akush Ginekol (Mosk); 1973 Mar; 49(3):16-7. PubMed ID: 4760960
[No Abstract] [Full Text] [Related]
46. [Contributions to the change in properdin level of the blood serum and to the mechanism of the decrease in titer in connection with renal diseases].
SZEMERE G; SZABO M; SZEL E
Kiserl Orvostud; 1962 Sep; 14():340-6. PubMed ID: 13979915
[No Abstract] [Full Text] [Related]
47. [Agglutination titer of isoagglutinins in blood serum in cases of malignant neoplasms following zymosan stimulation].
Dobrek A; Maciejewski B; Majewski S
Pol Tyg Lek; 1975 Jan; 30(3):93-6. PubMed ID: 1110955
[No Abstract] [Full Text] [Related]
48. [The "properdin system" and some stomatological diseases. VI. Relation between the serum properdin titer and malignant epithelial neoplasms of the oral cavity. (Experimental contribution)].
NITTI G; PETTINI PL
Boll Soc Ital Biol Sper; 1962 Jul; 38():657-9. PubMed ID: 14480071
[No Abstract] [Full Text] [Related]
49. [The "properdin system" and some stomatological diseases. VII. Relation between the serum properdin titer and malignant connective tissue neoplasms of the oral cavity. (Experimental contribution)].
NITTI G; PETINI PL
Boll Soc Ital Biol Sper; 1962 Jul; 38():659-61. PubMed ID: 14480070
[No Abstract] [Full Text] [Related]
50. [Blood levels of properdin as a factor of non-specific immunity].
Mierwa A; Kubacki J; Homerska S; Kardaszewicz S
Wiad Lek; 1977 Mar; 30(6):423-8. PubMed ID: 848014
[No Abstract] [Full Text] [Related]
51. [Experimental studies on the properdin system of the rabbit. (III). On changes in the properdin titer under varying conditions].
YAMAMASU N
Nihon Saikingaku Zasshi; 1961 Oct; 16():873-6. PubMed ID: 14008819
[No Abstract] [Full Text] [Related]
52. [Experimental studies on the properdin system of the rabbit. (IV) Relationship of properdin titer and antibody-forming activity].
YAMAMASU N
Nihon Saikingaku Zasshi; 1961 Dec; 16():1084-9. PubMed ID: 14008820
[No Abstract] [Full Text] [Related]
53. [Behavior of the serum properdin titer in various diseases].
BARANDUN S; ISLIKER H
Helv Med Acta; 1959 Nov; 26():791-7. PubMed ID: 13796531
[No Abstract] [Full Text] [Related]
54. Properdin determination in human sera.
BIANCHI V; GHIRARDO G; SANGUINETI M
Acta Haematol; 1959 May; 21(5):295-300. PubMed ID: 13660749
[No Abstract] [Full Text] [Related]
55. Methods for the assay of properdin.
ISLIKER HC; LINDER E
Vox Sang; 1958 Jan; 3(1):23-36. PubMed ID: 13544226
[No Abstract] [Full Text] [Related]
56. Interpretation of properdin levels determined by phage neutralization technique.
COWAN KM
Science; 1958 Oct; 128(3327):778-9. PubMed ID: 13592254
[No Abstract] [Full Text] [Related]
57. An improved properdin titration, based on the elimination of an inhibitor.
WILLERS JM; PONDMAN KW; WINKLER KC
Vox Sang; 1959 Feb; 4(1):21-32. PubMed ID: 13648265
[No Abstract] [Full Text] [Related]
58. [Study on the behavior of properdin in obstetrics. Clinical contribution].
POLVANI F
Ann Ostet Ginecol; 1959; 81():664-92. PubMed ID: 14433924
[No Abstract] [Full Text] [Related]
59. Determination of serum properdin levels by immunodiffusion.
Westberg NG; McLean RH; Michael AF
Int Arch Allergy Appl Immunol; 1973; 44(1):155-60. PubMed ID: 4633166
[No Abstract] [Full Text] [Related]
60. [The "properdin system" and some stomatological diseases. I. Biological and clinical importance of properdin and description of the experimental methods].
LAFORGIA PD; PETTINI P
Boll Soc Ital Biol Sper; 1961 Nov; 37():1158-61. PubMed ID: 14461512
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
